Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Heart (British Cardiac Society)
|
April 1, 2010
The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction
P Bramlage, C Messer, N Bitterlich, et al.
European Heart Journal
|
February 13, 2001
Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study
S N Willich, J Müller-Nordhorn, M Kulig, et al.
European Journal of Preventive Cardiology
|
May 2, 2013
Smoking ban in public areas is associated with a reduced incidence of hospital admissions due to ST-elevation myocardial infarctions in non-smokers. Results from the Bremen STEMI Registry
J Schmucker, H Wienbergen, S Seide, et al.
Pneumologie (Stuttgart, Germany)
|
March 4, 2016
[Cannabis--Position Paper of the German Respiratory Society (DGP)]
M Kreuter, D Nowak, T Rüther, et al.
European Journal of Clinical Investigation
|
November 1, 1994
The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The HELP-Study Group. Heparin-induced extra-corporeal LDL-precipitation
P Schuff-Werner, H Gohlke, U Bartmann, et al.
Neurology
|
June 28, 2006
Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS
R Fernández-Santiago, M Sharma, J C Mueller, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 14, 2007
[Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)]
U Tebbe, C Messer, E Stammwitz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
July 18, 2013
In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469
C Urban, A Hamacher, H J Partke, et al.
Chemical Communications (Cambridge, England)
|
January 27, 2016
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors
D Diedrich, A Hamacher, C G W Gertzen, et al.
Zeitschrift Fur Kardiologie
|
August 7, 2001
[Current prescription practice of CSE inhibitors at clinic discharge after acute myocardial infarct]
H Wienbergen, R Schiele, A K Gitt, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Heart (British Cardiac Society)
|
April 1, 2010
The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction
P Bramlage, C Messer, N Bitterlich, et al.
European Heart Journal
|
February 13, 2001
Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study
S N Willich, J Müller-Nordhorn, M Kulig, et al.
European Journal of Preventive Cardiology
|
May 2, 2013
Smoking ban in public areas is associated with a reduced incidence of hospital admissions due to ST-elevation myocardial infarctions in non-smokers. Results from the Bremen STEMI Registry
J Schmucker, H Wienbergen, S Seide, et al.
Pneumologie (Stuttgart, Germany)
|
March 4, 2016
[Cannabis--Position Paper of the German Respiratory Society (DGP)]
M Kreuter, D Nowak, T Rüther, et al.
European Journal of Clinical Investigation
|
November 1, 1994
The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The HELP-Study Group. Heparin-induced extra-corporeal LDL-precipitation
P Schuff-Werner, H Gohlke, U Bartmann, et al.
Neurology
|
June 28, 2006
Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS
R Fernández-Santiago, M Sharma, J C Mueller, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 14, 2007
[Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)]
U Tebbe, C Messer, E Stammwitz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
July 18, 2013
In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469
C Urban, A Hamacher, H J Partke, et al.
Chemical Communications (Cambridge, England)
|
January 27, 2016
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors
D Diedrich, A Hamacher, C G W Gertzen, et al.
Zeitschrift Fur Kardiologie
|
August 7, 2001
[Current prescription practice of CSE inhibitors at clinic discharge after acute myocardial infarct]
H Wienbergen, R Schiele, A K Gitt, et al.
Page
of 9